QXM

Implanted Tibial Electrical Urinary Continence Device

Product code
QXM
Device name
Implanted Tibial Electrical Urinary Continence Device
Device class
Class 2
21 CFR
21 CFR 876.5305
Medical specialty
Gastroenterology, Urology
Marketing pathway
510(K)
Flag
Implant
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
4 (all years; only the last 3 years are listed here)

FDA classification definition

An implanted tibial electrical urinary continence device is an implanted prescription device that receives power from a non-implanted external power source to provide electrical stimulation of the tibial nerve in proximity to the ankle. The device is intended for the treatment of overactive bladder related symptoms of urge urinary incontinence, urinary urgency, urinary frequency and nocturia.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2026-07-28.

NumberDecision dateApplicantDevice nameSummary
K2536512026-07-28Bluewind Medical , Ltd.Revi SystemPDF
K2523912025-12-12Bluewind Medical , Ltd.Revi SystemPDF
K2400372024-05-02Bluewind Medical , Ltd.Revi™ SystemPDF

3 summaries are archived here for direct download.

Official FDA classification page: QXM
Classification and pathway per current FDA publications. Data from openFDA (CC0).